YTHDF1 and neoplasm: More excitingly, mice cured by YTHDF1 deficiency and ICI exhibited resistance to WT tumor rechallenge (Fig. 6F), indicating that this combination therapy could elicit effective and long-lasting immune memory that protected the mice from tumor relapse.